Clinical Trial Update: B-lymphocyte Depletion Using Rituximab in Chronic Fatigue Syndrome/ Myalgic Encephalopathy (CFS/ME). A Randomized Phase-III Study. [Phase 3]

View source ↗

Summary

Phase III randomized study evaluating rituximab for B-lymphocyte depletion in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue Syndrome
• Myalgic Encephalomyelitis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Haukeland University Hospital | Conditions: Chronic Fatigue Syndrome/ Myalgic Encephalitis (CFS/ME) | Phase 3 | Status: COMPLETED